Quote (Dad): "Any one know of more than $33 in the years it has been on the market?"
-----snip from Q report -----
Revenue - Our revenue for the three months ended September 30, 2013 was $6,460, compared to $0 for the same period in 2012. Revenue increased due to sales of Petrozene that were not realized in 2012.
Cost of Revenue – Cost of revenues (Petrozene) were $2,925 for the three months ended September 30, 2013 versus $0 for the same period in 2012. This is the cost related to purchasing and transporting the product.
----end snip ----------------
Due Diligence applied: It's there in the SEC filings.